Release Date: 14/06/12 13:11 Summary: Wilgar results infill previously undrilled areas Price Sensitive: Yes Download Document 1.92MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%